Cap-dependent translation initiation factor, eIF4E, is the target for Ouabain-mediated inhibition of HIF-1α

Biochemical Pharmacology
Ji CaoBo Yang

Abstract

Hypoxia-inducible factor 1 (HIF-1), a heterodimeric transcription factor that mediates the adaptation of tumor cells and tissues to the hypoxic microenvironment, has attracted considerable interest as a potential therapeutic target. Recently, HIF-1α has been recognized as the critical target of cardiac glycosides for cancer therapy, but the molecular mechanism of cardiac glycosides' inhibition of HIF-1α is still poorly understood. In the present study, we observed that neither HIF-1α mRNA levels nor HIF-1α protein degradation are affected by Ouabain. However, Ouabain was found to be associated with the regulation of HIF-1α translation. Basing on in silico, in vitro and ex vivo models of translation processing, further studies revealed that eIF4E plays a critical role in the inhibitory effect of Ouabain on HIF-1α protein synthesis, rather than mTORC1, eIF2α signaling or Na(+)/K(+)-ATPase inhibition. Mechanistically, Ouabain directly binds eIF4E, disrupts eIF4E/eIF4G association (200 μM, Inhibit rate =61 ± 3%) but not the eIF4E/mRNA complex formation (200 μM, Inhibit rate =18 ± 5%) both in vitro and in cells, thereby inhibiting the intracellular cap-dependent translation. The association between Ouabain and eIF4E not only raises ...Continue Reading

References

Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·G L WangG L Semenza
Jun 1, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Rok HumarEdouard J Battegay
Dec 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Alex KentsisKatherine L B Borden
Apr 20, 2005·The Journal of Cell Biology·Biljana CuljkovicKatherine L B Borden
Jun 23, 2006·Neoplasia : an International Journal for Oncology Research·Xiaolin WanLee J Helman
Apr 19, 2007·Cancer Metastasis Reviews·Peter Vaupel, Arnulf Mayer
Feb 9, 2008·Cell Death and Differentiation·E B Rankin, A J Giaccia
Mar 12, 2008·Molecular Interventions·Robert A NewmanKeith I Block
Mar 28, 2008·Therapeutic Drug Monitoring·Mohammad Al-Ghoul, Roland Valdes
Apr 24, 2008·The Journal of Biological Chemistry·Regina M YoungM Celeste Simon
Apr 30, 2008·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Nahum Sonenberg
May 27, 2008·Nature Reviews. Cancer·Mark W DewhirstBenjamin Moeller
Oct 11, 2008·Nature Reviews. Cancer·Bradly G Wouters, Marianne Koritzinsky
Nov 21, 2008·Proceedings of the National Academy of Sciences of the United States of America·Huafeng ZhangGregg L Semenza
Oct 23, 2010·Molecular Cell·Amar J MajmundarM Celeste Simon
Mar 3, 2011·Nature Reviews. Clinical Oncology·Sarah P Blagden, Anne E Willis
May 25, 2011·Nature Reviews. Cancer·William R Wilson, Michael P Hay
Sep 14, 2011·International Journal of Cancer. Journal International Du Cancer·Robert J BiggarMads Melbye
Apr 13, 2012·Medicinal Research Reviews·Yan JiaCarston R Wagner
Jun 9, 2012·Nature·James UniackeStephen Lee

❮ Previous
Next ❯

Citations

Jan 19, 2016·Expert Reviews in Molecular Medicine·Chunwan LuYafei Cai
Dec 7, 2014·Pflügers Archiv : European journal of physiology·Sergei N Orlov, Pavel Hamet
Aug 18, 2016·Frontiers in Physiology·Anna BogdanovaAntonio Martínez-Ruiz
Apr 20, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sergei N OrlovOlga D Lopina
Nov 19, 2014·Nature Communications·Ari L LandonRonald B Gartenhaus
Mar 11, 2017·Current Opinion in Oncology·Vidya P RamamurthyVincent C O Njar
Mar 21, 2019·American Journal of Physiology. Lung Cellular and Molecular Physiology·Luciano AmarelleJacob I Sznajder
May 11, 2019·Journal of Cellular Biochemistry·Asiya BatoolKhurshid I Andrabi
Nov 25, 2020·Investigational New Drugs·Blake A JacobsonRobert A Kratzke
Nov 16, 2020·Genomics·Shi-Long JiangWen-Xu Hong
Nov 26, 2019·Biochemistry·Rishi Kumar MishraTanweer Hussain
Dec 8, 2020·Biochemistry. Biokhimii︠a︡·S E DmitrievK A Lashkevich
Feb 27, 2021·Molecular Cancer·Lei MiaoLeaf Huang
May 21, 2021·Oncotarget·Milagros SuarezLeonidas C Platanias

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.